Mumbai, Sep 15 : Jubilant Pharmova Ltd, an integrated global pharmaceutical company, said it has appointed Dr. Jaidev Rajpal as Head of its Generics business effective from October 11.
Rajpal is being appointed as Managing Director and CEO of the Company’s wholly owned subsidiary, Jubilant Generics Ltd, which is involved in the development, manufacturing and distribution of formulations to the US and non-US markets and is also involved in the India branded pharmaceuticals business.
Rajpal has over two decades of rich experience in management consulting, advising and transforming leading generic pharmaceutical companies in India and global markets. He has a track record of delivering business transformation projects.
He will take over the generics business from Pramod Yadav, who will continue to be the CEO of the Specialty Pharma (Radiopharma and Allergy Immunotherapy) and CDMO-Sterile Injectables businesses.
Shyam S. Bhartia, Chairman, and Hari S. Bhartia, Co-Chairman and Managing Director, Jubilant Pharmova Ltd, said: ”We are extremely pleased to have Jaidev with us in our endeavour to transform our generics business to supplement performance of the overall company.
“We are confident that with his rich experience and expertise in business transformation, Jaidev will add great value to our Generics business.”(UNI)